U.S. stocks closed higher, both on the day and the week, despite an exhausting roller-coaster week. S&P 500 and Nasdaq post ...

U.S. stocks were set to wrap up a wild week for markets with a modest decline on Friday. But despite the pullback, the S&P 500 and Nasdaq Composite were still on track to tally their best week of the ...

UBS analyst Stephen Ju lowered the firm’s price target on Pinterest (PINS) to $39 from $50 and keeps a Buy rating on the shares. Advertisers ...

The Invesco QQQ Trust tumbled Thursday after surging 12% yesterday following President Trump's announcement of a 90-day pause ...

Oppenheimer analyst Jason Helfstein lowered the firm’s price target on Pinterest to $36 from $50 and keeps an Outperform rating on the shares.

In a report released today, Thomas Champion from Piper Sandler maintained a Hold rating on Pinterest (PINS – Research Report), with a price ...

Piper Sandler analyst Thomas Champion lowered the firm’s price target on Pinterest (PINS) to $34 from $41 and keeps a Neutral rating on the ...

Wall Street experienced another volatile trading session on Tuesday as tariffs remained on top of investors' minds. Read more ...

KeyBanc analyst Justin Patterson lowered the firm’s price target on Pinterest (PINS) to $37 from $41 and keeps an Overweight rating on the ...

BofA analyst Justin Post lowered the firm’s price target on Pinterest (PINS) to $35 from $46 and keeps a Buy rating on the shares. Recent ...

Pfizer's top-selling product last year was Eliquis, which it co-markets with Bristol Myers Squibb. The blood thinner ...

First off, Robinhood's stock has risen sharply, as noted above. That has pushed its valuation to a worrying level. To put ...